#METABOLOMICS WORKBENCH cbeekman_20240117_122530 DATATRACK_ID:4592 STUDY_ID:ST003141 ANALYSIS_ID:AN005154
VERSION                          	1
CREATED_ON                       	03-27-2024
#PROJECT
PR:PROJECT_TITLE                 	Spatial analysis of murine GI reveals role of small intestinal bile acid
PR:PROJECT_TITLE                 	metabolism in amoxicillin-induced dysbiosis
PR:PROJECT_SUMMARY               	Antibiotics cause collateral damage to resident microbes that is associated with
PR:PROJECT_SUMMARY               	various health risks. To-date, studies have largely focused on impacts of
PR:PROJECT_SUMMARY               	antibiotics on large intestinal and fecal microbiota. Here, we employ a GI-wide
PR:PROJECT_SUMMARY               	integrated multiomic approach to reveal that amoxicillin (AMX) treatment reduces
PR:PROJECT_SUMMARY               	overall bacterial abundance, bile salt hydrolase activity and unconjugated bile
PR:PROJECT_SUMMARY               	acids in the small intestine (SI). An accompanying loss of fatty acids and
PR:PROJECT_SUMMARY               	increase in acyl-carnitines in the large intestine corresponded with
PR:PROJECT_SUMMARY               	spatially-distinct expansions of proteobacteria. Parasutterella
PR:PROJECT_SUMMARY               	excrementihominis utilized fatty acid biosynthesis, becoming dominant in the SI
PR:PROJECT_SUMMARY               	while multiple Klebsiella species employed fatty acid oxidation during expansion
PR:PROJECT_SUMMARY               	in the large intestine. Depletion of bile acids and lipids may contribute to
PR:PROJECT_SUMMARY               	AMX-induced dysbiosis in the lower GI. To test this, we demonstrate that
PR:PROJECT_SUMMARY               	restoration of unconjugated bile acids can mitigate losses of commensals in the
PR:PROJECT_SUMMARY               	large intestine while also inhibiting the expansion of Proteobacteria during AMX
PR:PROJECT_SUMMARY               	treatment.
PR:INSTITUTE                     	Brown University
PR:DEPARTMENT                    	MMI
PR:LABORATORY                    	MMI, Belenky Lab
PR:LAST_NAME                     	Beekman
PR:FIRST_NAME                    	Chapman
PR:ADDRESS                       	BMC 613, 171 Meeting Street, Providence RI 02912
PR:EMAIL                         	Chapman_Beekman@brown.edu
PR:PHONE                         	4012071832
PR:DOI                           	http://dx.doi.org/10.21228/M8DD95
#STUDY
ST:STUDY_TITLE                   	untargeted metabolomic analysis of whole blood from AMX-treated and untreated
ST:STUDY_TITLE                   	mice
ST:STUDY_SUMMARY                 	untargeted metabolomic analysis of whole blood from AMX-treated and untreated
ST:STUDY_SUMMARY                 	mice
ST:INSTITUTE                     	Brown University
ST:LAST_NAME                     	Beekman
ST:FIRST_NAME                    	Chapman
ST:ADDRESS                       	171 Meeting Street, Providence, Rhode Island, 02912, USA
ST:EMAIL                         	Chapman_Beekman@brown.edu
ST:PHONE                         	4012071832
ST:SUBMIT_DATE                   	2024-01-17
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	Mouse1	CB73	Treatment:Amox	GI_site=Blood; plate_nr=SPB83Z; position=H1
SUBJECT_SAMPLE_FACTORS           	Mouse2	CB74	Treatment:Amox	GI_site=Blood; plate_nr=SPB83Z; position=H2
SUBJECT_SAMPLE_FACTORS           	Mouse3	CB75	Treatment:Amox	GI_site=Blood; plate_nr=SPB83Z; position=H3
SUBJECT_SAMPLE_FACTORS           	Mouse7	CB79	Treatment:Amox	GI_site=Blood; plate_nr=SPB83Z; position=H7
SUBJECT_SAMPLE_FACTORS           	Mouse8	CB80	Treatment:Amox	GI_site=Blood; plate_nr=SPB83Z; position=H8
SUBJECT_SAMPLE_FACTORS           	Mouse9	CB81	Treatment:Amox	GI_site=Blood; plate_nr=SPB83Z; position=H9
SUBJECT_SAMPLE_FACTORS           	Mouse4	CB76	Treatment:Control	GI_site=Blood; plate_nr=SPB83Z; position=H4
SUBJECT_SAMPLE_FACTORS           	Mouse5	CB77	Treatment:Control	GI_site=Blood; plate_nr=SPB83Z; position=H5
SUBJECT_SAMPLE_FACTORS           	Mouse6	CB78	Treatment:Control	GI_site=Blood; plate_nr=SPB83Z; position=H6
SUBJECT_SAMPLE_FACTORS           	Mouse10	CB82	Treatment:Control	GI_site=Blood; plate_nr=SPB83Z; position=H10
SUBJECT_SAMPLE_FACTORS           	Mouse11	CB83	Treatment:Control	GI_site=Blood; plate_nr=SPB83Z; position=H11
SUBJECT_SAMPLE_FACTORS           	Mouse12	CB84	Treatment:Control	GI_site=Blood; plate_nr=SPB83Z; position=H12
#COLLECTION
CO:COLLECTION_SUMMARY            	Lumenal contents collected from multiple GI sites and immediately flash frozen
CO:SAMPLE_TYPE                   	Blood (whole)
#TREATMENT
TR:TREATMENT_SUMMARY             	Mice were treated for 24h with amoxicillin/vehicle in drinking water
TR:TREATMENT_COMPOUND            	Amoxicillin
TR:TREATMENT_ROUTE               	oral
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Frozen GI contents were lyophilized and 10mg of dry contents were extracted
SP:SAMPLEPREP_SUMMARY            	twice in 300µL in (2:1) acetone and isopropanol. Samples were maintained on dry
SP:SAMPLEPREP_SUMMARY            	ice during extraction steps. Extracts were diluted 1:10 in a solution of 80%
SP:SAMPLEPREP_SUMMARY            	methanol in water. All solvents were LC-MS grade purchased from Fisher
SP:SAMPLEPREP_SUMMARY            	Scientific.
#CHROMATOGRAPHY
CH:INSTRUMENT_NAME               	none
CH:COLUMN_NAME                   	none
CH:COLUMN_TEMPERATURE            	na
CH:FLOW_GRADIENT                 	none
CH:FLOW_RATE                     	na
CH:SOLVENT_A                     	none
CH:SOLVENT_B                     	none
CH:CHROMATOGRAPHY_TYPE           	None (Direct infusion)
#ANALYSIS
AN:LABORATORY_NAME               	General Metabolics
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6550 QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:MS_COMMENTS                   	A pooled study sample (pSS) was prepared by combining 5 µL of each sample. The
MS:MS_COMMENTS                   	pSS was injected every ten samples during data acquisition. Instrumental
MS:MS_COMMENTS                   	Analysis Metabolome profiles of the sample extracts were acquired using
MS:MS_COMMENTS                   	flow-injection mass spectrometry. The method described here is adapted from
MS:MS_COMMENTS                   	Fuhrer et al 2011. The instrumentation consisted of an Agilent 6550 iFunnel
MS:MS_COMMENTS                   	LC-MS Q-TOF mass spectrometer in tandem with an MPS3 autosampler (Gerstel) and
MS:MS_COMMENTS                   	an Agilent 1260 Infinity II quaternary pump. The running buffer was 60%
MS:MS_COMMENTS                   	isopropanol in water (v/v) with 1 mM ammonium fluoride. Hexakis (1H, 1H,
MS:MS_COMMENTS                   	3H-tetrafluoropropoxy)-phosphazene) (Agilent) and 3-amino-1-propanesulfonic acid
MS:MS_COMMENTS                   	(HOT) (Sigma Aldrich) were added to the running buffer to serve as lockmasses.
MS:MS_COMMENTS                   	The isocratic flow rate was set to 0.150 mL/min. The instrument was run in 4GHz
MS:MS_COMMENTS                   	High Resolution, negative ionization mode. Mass spectra between 50 and 1,000 m/z
MS:MS_COMMENTS                   	were collected in profile mode. 5 µL of each sample were injected twice,
MS:MS_COMMENTS                   	consecutively, within 0.96 minutes to serve as technical replicates. The pooled
MS:MS_COMMENTS                   	study sample was injected periodically throughout the batch. Data Processing &
MS:MS_COMMENTS                   	Annotation Raw profile data were centroided, merged, and recalibrated using
MS:MS_COMMENTS                   	MATLAB software described by Fuhrer et al(doi/10.1021/ac201267k).
MS:ION_MODE                      	NEGATIVE
MS:MS_RESULTS_FILE               	ST003141_AN005154_Results.txt	UNITS:ion counts	Has m/z:Yes
#END